Bachem Holding stock

BANB · SIX · CHF

Compare Bachem Holding
CHF 76.20Change from previous close: −4.39%Absolute change: −CHF 3.50

Close · November 20, 2026

Price history

+54.13% over the period

1 year: from CHF 49.44 (November 20, 2025) to CHF 76.20 (November 20, 2026), +54.13%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026CHF 76.20
October 30, 2026CHF 84.05
September 30, 2026CHF 81.05
August 31, 2026CHF 75.60
July 31, 2026CHF 74.80
June 30, 2026CHF 75.65
May 29, 2026CHF 76.85
April 30, 2026CHF 70.80
March 31, 2026CHF 64.85
February 27, 2026CHF 59.40
January 30, 2026CHF 70.00
December 30, 2025CHF 59.90
November 28, 2025CHF 51.85
November 20, 2025CHF 49.44

At a glance

  • The company

    Develop and produce peptide and oligonucleotide active pharmaceutical ingredients for pharmaceutical and biotechnology companies

  • Latest results

    Quarter to June 30, 2026 · EPS CHF 0.67

TickerLandia's take on Bachem Holding

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowCHF 48.68
52-wk highCHF 86.00

−11.40% from the 52-week high

Analysts · 10 analysts

Average targetCHF 84.30+10.63% vs. price

Buy 6 · Hold 3 · Sell 1 · Buy

TickerLandia Fingerprint: Bachem Holding

Compared with similar companies: very high earnings stability.

Financials and price compared with 61 companies in the biotechnology industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Bachem Holding is priced as in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Bachem Holding's P/E today is 38.4, in line with the median of its last 10 fiscal years (41.5; between 29.7 and 88.5 from 2016 to 2025). Bachem Holding's P/E (trailing 12 months): 38.7, in line with the median of a group of 9 similar companies (38.7).

P/E compared with its history

Compared with 9 similar companies

Bachem Holding's metrics compared with similar companies
MetricBachem HoldingPosition in the groupBand
P/E (trailing 12 months)38.7Middle
Forward P/E24.9Low
Operating margin21.8%Middle
ROE10.6%Middle
Debt/equity0.14High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Bachem Holding. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

CHF 326.45M

Latest quarter · Q2 2026

Net income

CHF 50.27M

Latest quarter · Q2 2026

Quarterly net margin

15.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
CHF 5.74B
P/E
38.7
EPS
CHF 1.98
Volume
58.82K
Daily trading
€6.58M
Dividend yield
1.18%
Last ex-dividend on May 4, 2026

How Bachem Holding is changing

All results
  • Revenue grew 11.6% a year on average over the last 5 years

  • Less cash than profit: free cash flow equal to -50% of net income

  • Shares outstanding up 7.1% in 5 years

Returns

Bachem Holding returns with dividends

CHF 1,000 invested in Bachem Holding 5 years ago, on November 22, 2021, would be worth CHF 588 today with dividends reinvested: −41.18% in total, −10.08% per year. On price alone it would be CHF 557 (−44.30%).

PeriodBachem HoldingSMICHF 1,000 becomes
1 month−11.40%+0.65%CHF 886
6 months−2.87%+8.75%CHF 971
Year to date+27.21%+9.83%CHF 1,272
1 year+56.00%+16.18%CHF 1,560
3 years+11.63%+35.68%CHF 1,116
5 years−41.18%+16.48%CHF 588
10 years+408.40%+85.64%CHF 5,084

Over the last 6 months it has done better than 11% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment

The chart in detail

Bachem Holding: technical analysis

Bachem Holding shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 54.5% below its all-time closing high (CHF 167.60, October 15, 2021).

Trend
No clear trend
RSI (14 sessions)
36
Between 30 and 70
vs 200-session average
+4.39%

Active signals

  • Close below the low of the previous 20 sessions.

  • Trading on November 20, 2026 was 2.4 times the 20-session average.

Support and resistance

Price areas where Bachem Holding has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. ResistanceCHF 83.15+9.12%6 touches, last on October 6, 2026
  2. ResistanceCHF 79.98+4.96%5 touches, last on October 23, 2026
  3. ResistanceCHF 77.60+1.84%2 touches, last on November 6, 2026
  4. Last priceCHF 76.20
  5. SupportCHF 74.44−2.31%4 touches, last on September 17, 2026
  6. SupportCHF 69.10−9.32%2 touches, last on July 30, 2026
  7. SupportCHF 66.96−12.12%4 touches, last on April 24, 2026

Volatility and risk

Over the last year it has moved less than the SMI.

Beta (1 year) vs SMI
0.79
Volatility (60 sessions, annualised)
28.2%
Largest fall in the last year
−26.97%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Bachem Holding: seasonality

Average monthly price change over 29 years

−0.5%Jan−0.2%Feb+5.1%Mar+2.7%Apr+0.7%May−1.4%Jun+1.1%Jul+1.4%Aug−2.2%Sep+2.0%Oct−2.0%Nov+2.9%Dec

Over the last 29 years, the strongest month for Bachem Holding has been March: +5.10% on average, positive in 19 years out of 28. The weakest has been September: −2.19% on average, positive in 9 years out of 29. November, the current month, has been positive in 8 years out of 28 (−1.99% on average).

Show chart data
MonthAverageMedianPositive years
January−0.46%+0.64%17 of 28
February−0.18%−1.18%11 of 28
March+5.10%+5.05%19 of 28
April+2.70%+1.15%18 of 28
May+0.70%−0.19%13 of 28
June−1.41%−0.88%12 of 28
July+1.09%−0.52%13 of 28
August+1.44%+0.78%15 of 29
September−2.19%−0.70%9 of 29
October+2.00%+0.57%15 of 29
November−1.99%−2.86%8 of 28
December+2.88%+3.12%19 of 28

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Bachem Holding and its competitors

Pharmaceutical and biotech companies around the world rely on Bachem Holding AG, which develops and manufactures peptide active pharmaceutical ingredients. Its portfolio spans peptide and oligonucleotide new chemical entities, commercial new chemical entities and generics. Alongside production, the group provides project management, analytical services, quality and regulatory work, research-grade production and supply services.

Headquarters
Bubendorf, Switzerland
Employees
2,725
Founded
1971
Chief executive
Anne-Kathrin Stoller
Bachem Holding and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Bachem HoldingBANB$6.84B21.8%38.7−2.87%
ABIVAXABVX$6.06B-6,270.4%—−38.78%
ALK-AbellóALK.B$7.79B26.6%38.0−7.14%
CamurusCAMX$4.32B37.4%58.7+37.97%
Financière de TubizeTUB$11.25B0.0%104.1+9.99%
Bavarian NordicBAVA$2.72B18.1%12.7+24.00%

Same industry or related industries, similar size. Compare Bachem Holding with its competitors · Full profile